A RTC which replaced anthracycline in 7+3 with gemtuzumab for older denovo AML patients did not improve outcomes and had increased toxicity. A reminder that ADC / Targeted therapeutics do not always trump conventional chemotherapy.
Read the full article here
Read the full article here
The widening scope and scale of genetic tests are posing new challenges, and the need to address these challenges is becoming immediately relevant for all…
Dr. Smith-Whitley, pediatric hematologist at the Children’s Hospital of Philadelphia, discusses the advances in sickle cell disease.
Dr. Varshavsky-Yanovsky discusses the safety of elranatamab in Black or African-American patients with multiple myeloma.
Bill Grambley explains how his company attacks health inequalities by providing personalized pharmaceutical care with an AI based platform.
Did you guess right? Check your answers below, and take the full quizzes to learn more! A. Two-finger technique B. Two-thumb-encircling-hands technique C. Hands-only CPR…
This Medical News article discusses research on health information being shared on the social media platform.
